Breakthrough innovation specialist Cambridge Consultants has won two prestigious iF DESIGN AWARDS. The awards, in the professional concept category, are for Aalto, an injection device for rheumatoid arthritis patients, and Alma, a smart cooling case for injectable fertility drugs. These awards are the latest in a series of accolades for Cambridge Consultants’ team of world-class designers.

We help our customers develop breakthrough products and services within their market.

This year’s iF DESIGN AWARDS attracted 7,300 entries from 56 countries. The hotly-contested awards were judged by a panel of 78 independent, international design experts.

The Alma concept emerged from interactions with IVF patients and fertility experts. During the IVF process injectable fertility drugs need to be stored at a specific temperature and taken at specific times, this has a significant impact on the patient’s lifestyle and wellbeing. Our team used their experience to design a potential solution. The resulting concept was a smart cooling case that gives the patient more personal freedom through their IVF process. The case controls the temperature of injectable fertility medication, ensuring they remain at optimum potency for the treatment. By removing the necessity to inject at home, it empowers the patient to lead a normal life during their IVF treatment.

“We are delighted that our work has been recognized with this award,” said Daisy Prior, who led the Alma project. “This work has meant a lot to everyone involved, as it directly addresses an unmet need for women during the challenges of IVF treatment, and has the potential to improve the user’s quality of life.”

The second award was for Aalto, an injection device for rheumatoid arthritis patients. Rheumatoid arthritis patients often have reduced dexterity caused by their condition; this can mean that they are unable to safely self-inject using standard injection devices. Patients risk injury and inaccurate dosing because injections cannot be administered effectively.

The Aalto concept is an electro-mechanical autoinjector that is designed specifically for use by patients with this reduced dexterity. By automating stages of the injection process, such as medication loading and needle assembly, user steps that previously had the potential to cause harm, now happen safely within the device.

“As designers, we are continually trying to challenge the status quo and move design forward,” said Harry Moorman, one of our leading designers. “So it’s great for our team to get this recognition for the work we put into Aalto.”

Lai Tang, Head of Design, Medical Technology, added, “At Cambridge Consultants our designers and human factors engineers work very closely with the technology and engineering disciplines to ensure the best possible solutions. It’s only by taking a truly holistic approach can we ensure our designs don’t simply meet the needs of the users, but exceed their expectations. It’s important for our design team to remain on the cutting edge, so it's especially pleasing to once again be rewarded with international design award success.”

Notes to editors

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of more than 850 staff, including engineers, scientists, mathematicians and designers, in offices in Cambridge (UK), Boston (USA), Tokyo and Singapore, Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, digital health, energy and wireless communications. For more information, visit:

Cambridge Consultants is part of Altran. Altran is the world leader in engineering and R&D services. Altran offers its clients a unique value proposition to meet their transformation and innovation challenges. Altran supports its clients, from concept through industrialization, to develop the products and services of tomorrow and has been working for more than 35 years with major players in many sectors: Automotive, Aeronautics, Space, Defense & Naval, Rail, Infrastructure & Transport, Energy, Industrial & Consumer, Life Sciences, Communications, Semiconductor & Electronics, Software & Internet, Finance & Public Sector. Altran has more than 50,000 employees operating in over 30 countries. Altran is an integral part of Capgemini, a global leader in consulting, digital transformation, technology and engineering services. The Group is at the forefront of innovation to address the entire breadth of clients’ opportunities in the evolving world of cloud, digital and platforms. Building on its strong 50-year + heritage and deep industry-specific expertise, Capgemini enables organizations to realize their business ambitions through an array of services from strategy to operations. Capgemini is driven by the conviction that the business value of technology comes from and through people. Today, it is a multicultural company of 270,000 team members in almost 50 countries. With Altran, the Group reported 2019 combined revenues of €17billion. People matter, results count. Visit us at

Media downloads

Aalto.jpg, 0.3MB
Alma.jpg, 1.9MB


Ketchum UK

Account Director